145 related articles for article (PubMed ID: 1380083)
21. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
Campbell BM; Kreipke CW; Walker PD
Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
[TBL] [Abstract][Full Text] [Related]
22. Stimulated serotonin release from hyperinnervated terminals subsequent to neonatal dopamine depletion regulates striatal tachykinin, but not enkephalin gene expression.
Basura GJ; Walker PD
Brain Res Mol Brain Res; 2000 Sep; 81(1-2):80-91. PubMed ID: 11000480
[TBL] [Abstract][Full Text] [Related]
23. Metabotropic glutamate receptor agonist increases neuropeptide mRNA expression in rat striatum.
Wang JQ; McGinty JF
Brain Res Mol Brain Res; 1998 Mar; 54(2):262-9. PubMed ID: 9555048
[TBL] [Abstract][Full Text] [Related]
24. Chronic dizocilpine maleate (MK-801) treatment suppresses the effects of nigrostriatal dopamine deafferentation on enkephalin but not on substance P expression in the rat striatum.
Hajji MD; Salin P; Kerkerian-Le Goff L
Eur J Neurosci; 1996 May; 8(5):917-26. PubMed ID: 8743739
[TBL] [Abstract][Full Text] [Related]
25. Differential changes in striatal projection neurons in R6/2 transgenic mice for Huntington's disease.
Sun Z; Del Mar N; Meade C; Goldowitz D; Reiner A
Neurobiol Dis; 2002 Dec; 11(3):369-85. PubMed ID: 12586547
[TBL] [Abstract][Full Text] [Related]
26. Glucocorticoid regulation of neuropeptide mRNAs in the rat striatum.
Chao HM; McEwen BS
Brain Res Mol Brain Res; 1991 Mar; 9(4):307-11. PubMed ID: 1645434
[TBL] [Abstract][Full Text] [Related]
27. L-DOPA-induced dyskinesia in the rat is associated with striatal overexpression of prodynorphin- and glutamic acid decarboxylase mRNA.
Cenci MA; Lee CS; Björklund A
Eur J Neurosci; 1998 Aug; 10(8):2694-706. PubMed ID: 9767399
[TBL] [Abstract][Full Text] [Related]
28. Prevention of levodopa-induced dyskinesias by a selective NR1A/2B N-methyl-D-aspartate receptor antagonist in parkinsonian monkeys: implication of preproenkephalin.
Morissette M; Dridi M; Calon F; Hadj Tahar A; Meltzer LT; Bédard PJ; Di Paolo T
Mov Disord; 2006 Jan; 21(1):9-17. PubMed ID: 16127720
[TBL] [Abstract][Full Text] [Related]
29. Repeated administration of cocaine, nicotine and ethanol: effects on preprodynorphin, preprotachykinin A and preproenkephalin mRNA expression in the dorsal and the ventral striatum of the rat.
Mathieu-Kia AM; Besson MJ
Brain Res Mol Brain Res; 1998 Feb; 54(1):141-51. PubMed ID: 9526067
[TBL] [Abstract][Full Text] [Related]
30. GABAergic regulation of enkephalin in rat striatum: alterations in Met5-enkephalin level, precursor content and preproenkephalin messenger RNA abundance.
Sivam SP; Hong JS
J Pharmacol Exp Ther; 1986 Apr; 237(1):326-31. PubMed ID: 3754280
[TBL] [Abstract][Full Text] [Related]
31. Modulation of striatal enkephalinergic neurons by antipsychotic drugs.
Hong JS; Yoshikawa K; Kanamatsu T; Sabol SL
Fed Proc; 1985 Jun; 44(9):2535-9. PubMed ID: 3838946
[TBL] [Abstract][Full Text] [Related]
32. Dopaminergic regulation of striatonigral tachykinin and dynorphin gene expression: a study with the dopamine uptake inhibitor GBR-12909.
Sivam SP
Brain Res Mol Brain Res; 1996 Jan; 35(1-2):197-210. PubMed ID: 8717356
[TBL] [Abstract][Full Text] [Related]
33. Partial reversal of increased preproenkephalin messenger ribonucleic acid (mRNA) and decreased preprotachykinin mRNA by foetal dopamine cells in unilateral 6-hydroxydopamine-lesioned rat striatum parallels functional recovery.
Zeng BY; Jenner P; Marsden CD
Mov Disord; 1996 Jan; 11(1):43-52. PubMed ID: 8771066
[TBL] [Abstract][Full Text] [Related]
34. Gene-peptide relationships in the developing rat brain: the response of preproenkephalin mRNA and [Met5]-enkephalin to acute opioid antagonist (naltrexone) exposure.
Zagon IS; McLaughlin PJ
Brain Res Mol Brain Res; 1995 Oct; 33(1):111-20. PubMed ID: 8774952
[TBL] [Abstract][Full Text] [Related]
35. Early changes in neuropeptide mRNA expression in the striatum following reserpine treatment.
Harrison MB; Kumar S; Hubbard CA; Trugman JM
Exp Neurol; 2001 Feb; 167(2):321-8. PubMed ID: 11161620
[TBL] [Abstract][Full Text] [Related]
36. Fenfluramine-induced increase in preproenkephalin mRNA levels in the striatum: interaction between the serotonergic, glutamatergic, and dopaminergic systems.
Liste I; Muñoz A; Guerra MJ; Labandeira-Garcia JL
Synapse; 2000 Mar; 35(3):182-91. PubMed ID: 10657025
[TBL] [Abstract][Full Text] [Related]
37. Preproenkephalin mRNA and methionine-enkephalin content are increased in mouse striatum after treatment with nicotine.
Dhatt RK; Gudehithlu KP; Wemlinger TA; Tejwani GA; Neff NH; Hadjiconstantinou M
J Neurochem; 1995 Apr; 64(4):1878-83. PubMed ID: 7891117
[TBL] [Abstract][Full Text] [Related]
38. NMDA receptors mediate amphetamine-induced upregulation of zif/268 and preprodynorphin mRNA expression in rat striatum.
Wang JQ; Daunais JB; McGinty JF
Synapse; 1994 Dec; 18(4):343-53. PubMed ID: 7886627
[TBL] [Abstract][Full Text] [Related]
39. Dopamine-dependent postnatal development of enkephalin and tachykinin neurons of rat basal ganglia.
Sivam SP; Krause JE; Breese GR; Hong JS
J Neurochem; 1991 May; 56(5):1499-508. PubMed ID: 1707436
[TBL] [Abstract][Full Text] [Related]
40. Chronic treatment with dizocilpine maleate increases the number of striatal neurons expressing the D2 receptor gene.
Lannes B; Bernard V; Bloch B; Micheletti G
Neuroscience; 1995 Mar; 65(2):431-8. PubMed ID: 7539897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
